Dolasetron Injection and Vemurafenib: Interaction Details

Brand names
Dolasetron Injection
Anzemet
Vemurafenib
Zelboraf
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Dolasetron Injection and Vemurafenib interaction:

Share

Share this interaction

Dolasetron Injection

Brand name
  • Anzemet

We don't have a drug information page for Dolasetron Injection yet. Have a question about Dolasetron Injection? Ask a pharmacist, free →

What Happens When You Take Dolasetron Injection With Vemurafenib

What can happen when they are taken together (rated Major)

Increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Vemurafenib should not be initiated in patients who are already taking another medication that is known to prolong the . Vemurafenib itself lengthens the QT interval, and this can raise the risk of serious cardiac adverse events, among them. When vemurafenib is given together with another QT-prolonging drug, the effects on the QT interval may be , which further elevates the risk of torsade de pointes.1

The Dolasetron Injection and Vemurafenib Interaction, Explained

Both dolasetron (Anzemet), an anti-nausea shot, and vemurafenib (Zelboraf), a melanoma medicine, can affect your heart's electrical rhythm. Each one can lengthen something called the . Taking them together may add up that effect and, rarely, lead to a serious irregular heartbeat called .

This concern is mostly based on how the drugs work rather than on reported cases. The labeling for vemurafenib advises against starting it when you already take another QT-prolonging drug. Your care team can manage this by choosing a different anti-nausea option or checking your heart rhythm more closely. Please don't change anything on your own. Talk with your pharmacist or doctor, and tell them right away if you feel faint, dizzy, or have a racing or fluttering heartbeat.

Interaction: () between dolasetron and vemurafenib, with increased risk of .

  • Mechanism: Vemurafenib causes concentration-dependent QT prolongation. Dolasetron (via its active hydrodolasetron) blocks cardiac sodium and hERG potassium channels, prolonging PR, QRS, and QT intervals. Effects are expected to be additive. No PK change is the basis of this interaction.
  • Evidence: theoretical; onset unspecified; severity rated major.
  • Management: Per labeling, do not initiate vemurafenib in patients receiving another QT-prolonging drug. Consider a non-QT-prolonging antiemetic alternative. If is unavoidable, individualize and consider and electrolyte (K, Mg) monitoring, and correct abnormalities.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Dolasetron Injection and Vemurafenib Interact

The likely mechanism


In short: Dolasetron injection and vemurafenib both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Dolasetron Injection and Vemurafenib Interaction

The documented advice is to avoid starting vemurafenib while someone is receiving another drug known to prolong the , and dolasetron is one of those drugs.

  • Your care team may review your full medicine list before treatment begins and consider whether a different anti-nausea medicine fits better.
  • If both are needed, your team may monitor you more closely and tailor your plan to your situation.
  • Keep taking your medicines as prescribed unless your prescriber tells you otherwise.
  • Tell your pharmacist or doctor about every medicine you take, and report fainting, dizziness, or a fast or irregular heartbeat right away.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Dolasetron Injection or Vemurafenib need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Dolasetron Injection and Vemurafenib: Common Questions

How serious is the Dolasetron Injection and Vemurafenib interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Dolasetron Injection and Vemurafenib interaction managed?

The documented advice is to avoid starting vemurafenib while someone is receiving another drug known to prolong the , and dolasetron is one of those drugs. Your care team may review your full medicine list before treatment begins and consider whether a different anti-nausea medicine fits better. If both are needed, your team may monitor you more closely and tailor your plan to your situ… Management is individual — always follow your own care team's guidance.

Is there an alternative to taking Dolasetron Injection with Vemurafenib?

The documented advice is to avoid starting vemurafenib while someone is receiving another drug known to prolong the , and dolasetron is one of those drugs. The record names this example:

Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Dolasetron Injection and Vemurafenib Interaction

Ask in your own words about taking Dolasetron Injection and Vemurafenib together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: ZELBORAF(R) oral tablets, vemurafenib oral tablets. Genentech USA, Inc. (per FDA), South San Francisco, CA, 2016. DailyMed
Was this write-up helpful?

Other Serious Interactions of Dolasetron Injection and Vemurafenib

Also serious with Dolasetron Injection

Also serious with Vemurafenib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Vemurafenib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.